# 22C Target Pharma Investors Rollover, LLC — Form D

22C Target Pharma Investors Rollover, LLC of NEW YORK, NY, a pooled investment fund, filed a Form D exempt-offering notice with the SEC on 2018-07-23. The offering totals $18.3M, of which $18.3M was reported sold. Industry: Pooled Investment Fund.

## Offering

- Filed: 2018-07-23
- Form: D
- Accession: 0000899140-18-000457
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.7
- Total offering: $18.3M
- Amount sold: $18.3M
- Investors: 4
- Date of first sale: 2018-06-28
- Security types: equity, fund interests
- SEC file number: 021-317493

## Issuer

- Name: 22C Target Pharma Investors Rollover, LLC
- CIK: 0001746768
- Entity type: Limited Liability Company
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 70 E 55TH STREET, 14TH FLOOR, NEW YORK, NY, 10022
- Phone: 212-224-0633

## Officers, directors & promoters (2)

| Name | Role | Location |
| --- | --- | --- |
| Eric Edell | Executive Officer | New York, NY |
| D. RANDALL WINN | Executive Officer | VANCOUVER, WA |

## More

- [CIK 1746768 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1746768&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0000899140-18-000457.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.